Journal article

Development and implementation of a novel assay for L-2-hydroxyglutarate dehydrogenase (L-2-HGDH) in cell lysates: L-2-HGDH deficiency in 15 patients with L-2-hydroxyglutaric aciduria


Authors listKranendijk, M.; Salomons, G. S.; Gibson, K. M.; Aktuglu-Zeybek, C.; Bekri, S.; Christensen, E.; Clarke, J.; Hahn, A.; Korman, S. H.; Mejaski-Bosnjak, V.; Superti-Furga, A.; Vianey-Saban, C.; van der Knaap, M. S.; Jakobs, C.; Struys, E. A.

Publication year2009

Pages713-719

JournalJournal of Inherited Metabolic Disease

Volume number32

Issue number6

ISSN0141-8955

eISSN1573-2665

DOI Linkhttps://doi.org/10.1007/s10545-009-1282-x

PublisherSpringer


Abstract
L-2-hydroxyglutaric aciduria (L-2-HGA) is a rare inherited autosomal recessive neurometabolic disorder caused by mutations in the gene encoding L-2-hydroxyglutarate dehydrogenase. An assay to evaluate L-2-hydroxyglutarate dehydrogenase (L-2-HGDH) activity in fibroblast, lymphoblast and/or lymphocyte lysates has hitherto been unavailable. We developed an L-2-HGDH enzyme assay in cell lysates based on the conversion of stable-isotope-labelled L-2-hydroxyglutarate to 2-ketoglutarate, which is converted into L-glutamate in situ. The formation of stable isotope labelled L-glutamate is therefore a direct measure of L-2-HGDH activity, and this product is detected by liquid chromatography-tandem mass spectrometry. A deficiency of L-2-HGDH activity was detected in cell lysates from 15 out of 15 L-2-HGA patients. Therefore, this specific assay confirmed the diagnosis unambiguously affirming the relationship between molecular and biochemical observations. Residual activity was detected in cells derived from one L-2-HGA patient. The L-2-HGDH assay will be valuable for examining in vitro riboflavin/FAD therapy to rescue L-2-HGDH activity.



Citation Styles

Harvard Citation styleKranendijk, M., Salomons, G., Gibson, K., Aktuglu-Zeybek, C., Bekri, S., Christensen, E., et al. (2009) Development and implementation of a novel assay for L-2-hydroxyglutarate dehydrogenase (L-2-HGDH) in cell lysates: L-2-HGDH deficiency in 15 patients with L-2-hydroxyglutaric aciduria, Journal of Inherited Metabolic Disease, 32(6), pp. 713-719. https://doi.org/10.1007/s10545-009-1282-x

APA Citation styleKranendijk, M., Salomons, G., Gibson, K., Aktuglu-Zeybek, C., Bekri, S., Christensen, E., Clarke, J., Hahn, A., Korman, S., Mejaski-Bosnjak, V., Superti-Furga, A., Vianey-Saban, C., van der Knaap, M., Jakobs, C., & Struys, E. (2009). Development and implementation of a novel assay for L-2-hydroxyglutarate dehydrogenase (L-2-HGDH) in cell lysates: L-2-HGDH deficiency in 15 patients with L-2-hydroxyglutaric aciduria. Journal of Inherited Metabolic Disease. 32(6), 713-719. https://doi.org/10.1007/s10545-009-1282-x



Keywords


ACIDEMIAD-2-HYDROXYGLUTARATE

Last updated on 2025-21-05 at 18:43